Gasparini P, Calonge M J, Bisceglia L, Purroy J, Dianzani I, Notarangelo A, Rousaud F, Gallucci M, Testar X, Ponzone A
Servizio di Genetica Medica, IRCCS-Ospedale CSS San Giovanni Rotondo, Italy.
Am J Hum Genet. 1995 Oct;57(4):781-8.
A cystinuria disease gene (rBAT) has been recently identified, and some mutations causing the disease have been described. The frequency of these mutations has been investigated in a large sample of 51 Italian and Spanish cystinuric patients. In addition, to identify new mutated alleles, genomic DNA has been analyzed by an accurate and sensitive method able to detect nucleotide changes. Because of the lack of information available on the genomic structure of rBAT gene, the study was carried out using the sequence data so far obtained by us. More than 70% of the entire coding sequence and 8 intron-exon boundaries have been analyzed. Four new mutations and seven intragenic polymorphisms have been detected. All mutations so far identified in rBAT belong only to cystinuria type I alleles, accounting for approximately 44% of all type I cystinuric chromosomes. Mutation M467T is the most common mutated allele in the Italian and Spanish populations. After analysis of 70% of the rBAT coding region, we have detected normal sequences in cystinuria type II and type III chromosomes. The presence of rBAT mutated alleles only in type I chromosomes of homozygous (type I/I) and heterozygous (type I/III) patients provides evidence for genetic heterogeneity where rBAT would be responsible only for type I cystinuria and suggests a complementation mechanism to explain the intermediate type I/type III phenotype.
最近已鉴定出一种胱氨酸尿症疾病基因(rBAT),并描述了一些导致该疾病的突变。在51名意大利和西班牙胱氨酸尿症患者的大样本中研究了这些突变的频率。此外,为了鉴定新的突变等位基因,采用了一种能够检测核苷酸变化的准确且灵敏的方法对基因组DNA进行了分析。由于缺乏关于rBAT基因基因组结构的可用信息,该研究使用了我们目前获得的序列数据进行。已对整个编码序列的70%以上以及8个内含子 - 外显子边界进行了分析。检测到4个新突变和7个基因内多态性。到目前为止在rBAT中鉴定出的所有突变仅属于I型胱氨酸尿症等位基因,约占所有I型胱氨酸尿症染色体的44%。突变M467T是意大利和西班牙人群中最常见的突变等位基因。在分析了rBAT编码区的70%后,我们在II型和III型胱氨酸尿症染色体中检测到正常序列。仅在纯合子(I/I型)和杂合子(I/III型)患者的I型染色体中存在rBAT突变等位基因,这为遗传异质性提供了证据,其中rBAT仅负责I型胱氨酸尿症,并提示了一种互补机制来解释中间型I/III型表型。